Alector Inc. cuts its workforce by nearly 50% following the failure of its dementia drug trial, signalling challenges in the ...
A lector, a once-high-flying Bay Area biotech company that researches treatments for degenerative brain disorders like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback